Targeted immunotherapy against triple negative breast cancer (TNBC) overexpressing Epidermal Growth factor (EGFR), chondroitin sulfate proteoglycan 4 (CSPG4) and CD44 receptors
Biotechnology
Part of the National Nanomedicine Seminar, this talk can be joined virtually on Teams.
Meeting ID: 227 149 154 916
Passcode: CW6dN7qX
Speakers
Dr. Fleury A Nsole Biteghe
Lecturer
Northeastern University